Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
30
NCT02966522
Thalidomide/Dexamethasone Treatment And PET Evaluation In Organ Involvemenet of Cardiac Amyloidosis
Phase: Phase 2
Role: Collaborator
Start: Oct 31, 2016
Completion: Sep 30, 2019